Chemotherapy With or Without Surgery in Treating Patients With Bladder Cancer (NCT00042887) | Clinical Trial Compass
TerminatedPhase 3
Chemotherapy With or Without Surgery in Treating Patients With Bladder Cancer
Stopped: low accrual
Belgium, Italy58 participantsStarted 2002-05
Plain-language summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Infusing chemotherapy drugs directly into the bladder may kill more cancer cells. It is not yet known if surgery followed by chemotherapy is more effective than chemotherapy alone in treating bladder cancer.
PURPOSE: Randomized phase III trial to compare the effectiveness of chemotherapy alone with that of transurethral resection followed by chemotherapy in treating patients who have bladder cancer.
Who can participate
Age range80 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
DISEASE CHARACTERISTICS:
* Cytologically confirmed solitary primary or recurrent papillary transitional cell carcinoma of the bladder
* Ta or T1
* Tumor no greater than 2 cm in diameter
* Negative urine cytology
* No suspicious lesions in bladder requiring biopsy
* No tumors in the prostatic urethra or upper urinary tract
* No prior history of T1 G3 tumors, muscle invasive tumors (T2 or greater), or carcinoma in situ
PATIENT CHARACTERISTICS:
Age
* 80 and under
Performance status
* WHO 0-1
Life expectancy
* Not specified
Hematopoietic
* Not specified
Hepatic
* Not specified
Renal
* Not specified
Other
* HIV negative
* No active intractable or uncontrollable bladder infection
* No urethral strictures that would preclude endoscopic procedures or repeated catheterization
* No prior or concurrent congenital or acquired immune deficiency syndrome
* No other prior or concurrent malignancy except cured basal cell skin cancer or intraepithelial cancer of the cervix
* No prior or concurrent leukemia or Hodgkin's disease
* No concurrent disease for which general anesthesia is contraindicated
* No psychological, familial, sociological, or geographical condition that would preclude study compliance
* Not pregnant or nursing
PRIOR CONCURRENT THERAPY:
Biologic therapy
* More than 12 months since prior BCG vaccine
Chemotherapy
* At least 1 year since prior mitomycin
Endocrine therapy
* Not specified
Radiotherapy
* No prior pelvic radiotherapy
Surgery
* No prior …
Trial details
NCT IDNCT00042887
SponsorEuropean Organisation for Research and Treatment of Cancer - EORTC